Back to companies
Stoke Therapeutics, Inc.
STOKUSNASDAQPharmaceuticals & HealthcareStoke Therapeutics, Inc.
Revenue
$184.4mn
YoY +404.5%
Operating income
-$20.6mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API